Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Direct head-to-head trials between Tirzepatide and Retatrutide have not been completed, but indirect comparisons suggest Retatrutide produces approximately 15% greater weight loss at maximum doses
The added glucagon receptor activation may enhance fat oxidation and increase energy expenditure beyond what dual agonists achieve
Disclaimer: This information is for educational purposes only and is not medical advice
But, for most of our members who come to us from a history of yo-yo dieting, the methods below are easier to keep up day-to-day
As these drugs advance through clinical trials and we see more studies like the groundbreaking Afrin research, they represent a new paradigm in hormone-based therapies with the possibility of reshaping how we approach not just metabolic health, but overall well-being
Key Takeaways Retatrutide is a breakthrough triple agonist peptide therapy targeting GLP-1, GIP, and glucagon receptors
US$ 23.19
US$ 29.90
US$ 29.02
US$ 24.21
US$ 25.27
US$ 24.06
US$ 27.30
